Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Overview

  • Peptide receptor radionuclide therapy (PRRT) is a molecular therapy which is also called radioisotope therapy. This type of therapy is used to treat a specific type of cancer called neuroendocrine tumors.
  • In peptide receptor radionuclide therapy, a targeting protein or peptide is combined with a small amount of radioactive material and injected into the patients’ bloodstream. This radiopeptide travels to and binds to neuroendocrine tumor cells, delivering a targeted high dose of radiation directly to the cancer cells.
  • The global peptide receptor radionuclide therapy (PRRT) market is projected to expand at a significant pace during the forecast period, owing to increase in incidence of mainly gastro-entero-pancreatic

Key Drivers of Global Peptide Receptor Radionuclide Therapy (PRRT) Market

  • Rise in awareness about effective use of peptide receptor radionuclide therapy is one of the important factors, which is likely to drive the market. Peptide receptor radionuclide therapy offers more personalized cancer treatment because radiopeptides are highly selective in their ability to specifically reach and damage neuroendocrine tumor cells, while limiting the radiation exposure.  This has increased the global demand for usage as therapy in treating neuroendocrine cancers.
  • Moreover, favorable reimbursement is likely to drive the market. Standard therapy with 177Lu-DOTATATE is approved by the FDA in the U.S. and by the EMA in the European Union.

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Peptide Receptor Radionuclide Therapy (PRRT) Market Report

Restraints of Global Peptide Receptor Radionuclide Therapy (PRRT) Market

  • Supply of radioisotopes is unstable globally and is expected to reduce in the near future due to shut down of major reactors (Canada and the Netherlands)
  • Short half-life radioisotopes cannot be supplied to other regions where the production of raw materials is negligible, as these disintegrate rapidly
  • Moreover, several patients may experience nausea and vomiting after the administration of the peptide receptor radionuclide therapy. This is managed with anti-nausea medication or slowing down the administration of the amino acids. Long-term side effects can include a suppression of blood cell counts, which is mild to moderate in the majority of cases associated with the therapy. This is expected to hamper the growth of the market.

North America to Account for Major Share of Global Peptide Receptor Radionuclide Therapy (PRRT) Market

  • Increase in access to health care, rise in incidence of cancer patients, and rapid introduction of advanced therapy and favourable reimbursement are some factors that likely to drive the market in North America
  • Asia Pacific is expected to grow at significant rate, owing to growing demand for advancement treatment options and comparatively high prevalence of cancer in countries such as India, Taiwan, and China

Stuck in a Neck-to-Neck Competition with Other Brands? Request a Custom Report on “Peptide Receptor Radionuclide Therapy (PRRT) Market” here

Key Players Operating in Global Peptide Receptor Radionuclide Therapy (PRRT) Market

Major players operating in the global peptide receptor radionuclide therapy (PRRT) market are:

  • Advanced Accelerator Applications SA (Novartis)

Global Peptide Receptor Radionuclide Therapy (PRRT) Market: Research Scope

Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Peptide Drug Type

  • Dotatoc
  • Dotatate

Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Indication

  • Foregut Neuroendocrine Tumors
  • Midgut Neuroendocrine Tumors
  • Hindgut Neuroendocrine Tumors

Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Indication

  • Hospitals
  • Cancer Care Centers
  • Others

Global Peptide Receptor Radionuclide Therapy (PRRT) Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Peptide Receptor Radionuclide Therapy Prrt Market

Pre Book